関連する実験動画
Updated: May 22, 2025

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
17.7K
レナカパビールの薬動学と安全性:フェーズ1のオープン試験
Vamshi Jogiraju1, Pallavi Pawar1, Jenna Yager1
1Gilead Sciences, Foster City, CA, USA.
Lancet (London, England)
|March 14, 2025
まとめ
1年に1回投与されたレナカパビルは,HIV感染前予防 (PrEP) の薬理動態と安全性を良好に示した. この長効薬は 生物医学的なHIV予防に 有望な新しい選択肢となり 潜在的に患者さんの健康状態を改善し 汚名を減らすことができます
科学分野:
- 薬理学と医薬品
- 感染症
- 臨床試験
背景:
- 長效抗レトロウイルス薬は,日常的なHIV暴露前予防 (PrEP) に伴うアデランスと汚名を解決します.
- 3期試験では,PREPの有効性と安全性が高いことが示されました.
- この研究は,レナカパヴィルの新しい,より頻繁な投与戦略を調査しています.
研究 の 目的:
- 1年に1回投与される2種類のレナカパヴィルの薬動学と安全性を評価する.
- 1年に1回投与されるレナカパヴィルの薬理学プロフィールと,年に2回投与される皮下注射のプロフィールを比較する.
- HIV予防の潜在的使用について,肌内レナカパヴィルの耐受性および安全性を評価する.
主な方法:
- ステージ1のオープンラベル研究で,HIV感染のない40人の参加者 (18~55歳) が参加した.
- 1年に1回投与される2種類のレナカパビル (5000mg単回投与量) を投与する.
- 注射部位の痛みを含む安全性および耐受性の評価
主要な成果:
- 両方ともピーク濃度に達する平均時間は約70~84日でした.
- プラズマ濃度と最低濃度の中央値は,年に2回投与されたレナカパヴィルより高かった.
- 副作用は主に軽度 (グレード1-2) で,注射部位の痛みが最も一般的であり,1週間以内に治りました.
結論:
- プラズマ濃度はPrEPの有効性と関連している濃度より高い.
- 両方とも安全で耐受性が良好であることが判明しました.
- これらの発見は,年に1回投与されるレナカパヴィールの生物医学的なHIV予防の可能性を裏付けています.
さらに関連する動画
関連する概念動画
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
67
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
67
One-Compartment Open Model for IV Bolus Administration: General Considerations
139
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
139
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
158
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
158
Analysis of Population Pharmacokinetic Data
208
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
208
Nonlinear Pharmacokinetics: Overview
240
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
240
Pharmacokinetics: Overview
5.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.4K

